ACVR1

Gene Information
 
Gene Symbol
ACVR1
 
Aliases
ACTRI, ACVR1A, ACVRLK2, ALK2, FOP, SKR1, TSRI
 
Entrez Gene ID
90
 
Gene Name
Activin A receptor type 1
 
Chromosomal Location
2q24.1
 
HGNC ID
 
Summary
Activins are dimeric growth and differentiation factors which belong to the transforming growth factor-beta (TGF-beta) superfamily of structurally related signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases which include at least two type I ( I and IB) and two type II (II and IIB) receptors. These receptors are all transmembrane proteins, composed of a ligand-binding extracellular domain with cysteine-rich region, a transmembrane domain, and a cytoplasmic domain with predicted serine/threonine specificity. Type I receptors are essential for signaling; and type II receptors are required for binding ligands and for expression of type I receptors. Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors. This gene encodes activin A type I receptor which signals a particular transcriptional response in concert with activin type II receptors. Mutations in this gene are associated with fibrodysplasia ossificans progressive. [provided by RefSeq, Jul 2008]
 
RefSeq DNA
 
RefSeq mRNA
  e!Ensembl
Gene
Transcript  
Protein

SNPs

SNP Id
Upstream Sequence
SNP
Downstream Sequence Functional Significance References
rs1220134 CTTGAGGATCATATTACTCCAAGAGA
A/T
CTATCTGGTCATCAATTTTTATAAT Intron variant 18854405
rs10497189 CCACAATATGCATCAAAATGTGTTCT
C/T
GGACATTAGTTATTCTTAATAAAGA Intron variant 18854405
rs2033962 GTGCCATAGACCTTTGGAGGGAGCTC
G/T
GAAAGCTGAATTTCCTAATATGAAC Intron variant 18854405

Gene Ontology (GO)

GO ID Ontology Function Evidence Reference
GO:0000082 Biological process G1/S transition of mitotic cell cycle IMP 9884026
GO:0003143 Biological process Embryonic heart tube morphogenesis IMP 19506109
GO:0003183 Biological process Mitral valve morphogenesis IMP 19506109
GO:0003289 Biological process Atrial septum primum morphogenesis IMP 19506109
GO:0006468 Biological process Protein phosphorylation IDA 12065756, 19506109
Protein Information
 
Protein Name
Activin receptor type-1, TGF-B superfamily receptor type I, activin A receptor, type I, activin A receptor, type II-like kinase 2, activin receptor type I, activin receptor-like kinase 2, hydroxyalkyl-protein kinase, serine/threonine-protein kinase receptor R1
 
Function
On ligand binding, forms a receptor complex consisting of two type II and two type I transmembrane serine/threonine kinases. Type II receptors phosphorylate and activate type I receptors which autophosphorylate, then bind and activate SMAD transcriptional regulators. Receptor for activin. May be involved for left-right pattern formation during embryogenesis (By similarity).
 
Refseq Proteins
 
UniProt
 
PDB
 
Pfam
Pfam Accession Pfam ID
PF01064 Activin_recp
PF07714 Pkinase_Tyr
PF08515 TGF_beta_GS
Pathways
 
KEGG
 
 

Cytokine-cytokine receptor interaction
TGF-beta signaling pathway
Signaling pathways regulating pluripotency of stem cells
Fluid shear stress and atherosclerosis

 

Interactions
 
STRING MINT IntAct
ENSP00000286548 P50148 P50148
    View interactions
     

Associated Diseases

Disease groupDisease NameReferences
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Genetic Diseases
Endocrine System Diseases
PCOS
Musculoskeletal Diseases
Fibrodysplasia Ossificans Progressiva
Neoplasms
Grade I Astrocytoma
Glioma
References
 
 
PubMed ID Associated gene/s Associated condition Genetic Mutation Diagnostic Criteria Association with PCOS Ethnicity Conclusion
AMH 
 
variation in gene 
Rotterdam criteria 
Related 
359 PCOS patients and 30 normo-ovulatory and 3543 population-based control women 
Genetic variation within ACVR1 is associated with AMH levels and follicle number in PCOS women, suggesting that ALK2 signalling contributes to the disturbed folliculogenesis in PCOS patients. 
 
 
 
 
Related 
PCOS WOMENS (n = 14) and normal controls (n = 21) 
This is the first report to demonstrate the aberrantly increased expression of betaglycan mRNA in PCOS ovaries. The mechanism by which betaglycan contributes to the pathologic process of PCOS remains to be clarified. 

| © 2019, Biomedical Informatics Centre, NIRRH |
National Institute for Research in Reproductive Health, Jehangir Merwanji Street, Parel, Mumbai-400 012
Tel: 91-22-24192104, Fax No: 91-22-24139412